Trial
NCT02595840
Biomarker Study Accompanying the AIO-TRK-0114 Study (MARBLE)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Universität Duisburg-Essen
Collaborators
—
Condition
Non-small-cell Lung Cancer With Somatic EGFR Mutations
Intervention
Afatinib
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-19